The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Prognostication of older Hodgkin lymphoma (HL) patients (pts): Findings from a multicenter phase II study.
 
Andrew M. Evens
Honoraria - Affimed Therapeutics; Celgene; Kite, a Gilead company; Merck; Millennium; Pharmacyclics; Seagen; Spectrum Pharmaceuticals
Consulting or Advisory Role - Affimed Therapeutics; Celgene; Kite, a Gilead company; Merck; Millennium; Pharmacyclics; Seagen; Spectrum Pharmaceuticals
Speakers' Bureau - Celgene
Research Funding - 3-V Biosciences; Celgene; Infinity Pharmaceuticals; Millennium; Tesaro
 
Ranjana H. Advani
Consulting or Advisory Role - AstraZeneca; Bayer; Bristol-Myers Squibb; Cell Medica; Genentech/Roche; Gilead Sciences; NanoString Technologies; Pharmacyclics; Seagen; Spectrum Pharmaceuticals; Sutter Medical Group
Research Funding - Agensys (Inst); Celgene (Inst); Forty Seven (Inst); Genentech/Roche (Inst); Infinity Pharmaceuticals (Inst); Janssen (Inst); Kura Oncology (Inst); Merck (Inst); Millennium (Inst); Pharmacyclics (Inst); Regeneron (Inst); Seagen (Inst)
 
Michelle A. Fanale
Honoraria - Bristol-Myers Squibb; Plexus; Research to Practice; Seagen; Takeda
Consulting or Advisory Role - Amgen; Bristol-Myers Squibb; Merck; Seagen; Spectrum Pharmaceuticals
Research Funding - ADC Therapeutics; Bristol-Myers Squibb; Celgene; Genentech; Gilead Sciences; MedImmune; Merck; Millennium; Molecular Templates; Novartis; Pharmacyclics; Seagen; Takeda
Travel, Accommodations, Expenses - Bristol-Myers Squibb; Merck; Plexus; Research to Practice; Seagen; Spectrum Pharmaceuticals; Takeda
 
Sonali M. Smith
Consulting or Advisory Role - Abbvie/Genentech; Amgen; AstraZeneca; Celgene; Forty Seven; Genmab; Gilead Sciences; Juno Therapeutics; Kite, a Gilead company; NanoString Technologies; Pharmacyclics; Portola Pharmaceuticals; Roche; TG Therapeutics
 
Irene B. Helenowski
No Relationships to Disclose
 
Gregory Bociek
Consulting or Advisory Role - Innate Pharma
 
Andreas Kirschmer Klein
No Relationships to Disclose
 
Jane N. Winter
Consulting or Advisory Role - Ariad (I); Bristol-Myers Squibb (I); Celgene (I); CVS Caremark (I); Novartis (I); Pfizer (I)
Research Funding - Astellas Pharma (Inst); Celgene (I); Curis; Daiichi Sankyo (I); ERYTECH Pharma (Inst); GlaxoSmithKline (Inst); Janssen Oncology (Inst); Merck
Patents, Royalties, Other Intellectual Property - Royalties from UptoDate, Inc. (I)
 
Leo I. Gordon
Patents, Royalties, Other Intellectual Property - Zylem
Other Relationship - Gilead Sciences
 
Paul A. Hamlin
No Relationships to Disclose